Aragon-Ching, J. B. (2019). Darolutamide: A novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer. Asian J Androl.
Chicago Style aipamenaAragon-Ching, Jeanny B. "Darolutamide: A Novel Androgen-signaling Agent in Nonmetastatic Castration-resistant Prostate Cancer." Asian J Androl 2019.
MLA aipamenaAragon-Ching, Jeanny B. "Darolutamide: A Novel Androgen-signaling Agent in Nonmetastatic Castration-resistant Prostate Cancer." Asian J Androl 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.